Project Grant K24HL181392
Award Date 8/18/25
Completion Date 7/31/30
Dollars Obligated $120K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
- This federal Project Grant award, valued at $187,798 and awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports a research project to design and pilot a community health worker (CHW) model for improving asthma care and outcomes among low-income children in Rochester, NY. The key objectives are to: 1) use implementation science methods to identify effective CHW asthma care components and assess...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $771,750 to Albert Einstein College of Medicine to conduct the "Promoting Asthma Guidelines and Management through Technology-Based Intervention and Care Coordination in Clinics and Schools" (PRAGMATIC-S) study. The project aims to create an innovative interface between primary care and school-based asthma management...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $731,130 project grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Children's Hospital Medical Center in Cincinnati, Ohio. The grant aims to conduct a two-stage, sequential, multiple assignment, randomized trial (SMART) to evaluate the effectiveness of a stepped-care mHealth intervention for improving adherence to daily inhaled corticosteroids in adolescents with asthma. The project will develop and...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $673,581 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Ochin, Inc., a nonprofit health IT organization based in Portland, Oregon. The project will assess disparities in asthma care utilization and outcomes between Latino and non-Hispanic white adults, and identify the underlying social determinants of health factors driving these disparities. The project will leverage Ochin's unique dataset...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $189,000 to the University of Colorado-Denver to investigate the role of outdoor air pollution and environmental allergens in driving treatment response for children with asthma exacerbations in the emergency department. The 2-year project aims to determine the association between these environmental factors and acute asthma treatment responsiveness. This work...
- This federal Project Grant award of $259,752, provided by the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837), aims to develop and pilot test an integrated intervention for older adults with uncontrolled asthma and comorbid depressive disorders. The project, conducted by the Icahn School of Medicine at Mount Sinai, will involve developing a 10-12 session program that combines asthma self-management support with cognitive behavioral therapy...
- This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under CFDA 93.837 Cardiovascular Diseases Research, will investigate how clinical, genetic, and social factors interact with ambient air pollution (AAP) to influence asthma exacerbations and long-term lung function in children. The $135,000 award, made on July 16, 2025, will enable the research team at the Children's Hospital of Philadelphia (CHOP) to: 1) Develop predictive models for asthma outcomes by...
- This federal Project Grant award of $616,814, funded by the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research), supports research focused on understanding the role of microRNAs in regulating airway smooth muscle function and their contribution to the pathogenesis of asthma. The overarching goal is to establish the in vivo role of key microRNA targets in regulating airway smooth muscle phenotypes, including proliferation, hypertrophy, and contractility, and...
- The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, awarded a $186,896 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Regents of the University of California, San Francisco. This 3-year grant, awarded on February 3, 2025, with a completion date of August 31, 2027, will evaluate the impact of screening for Adverse Childhood Experiences (ACEs) and providing behavioral-social support on health outcomes for...
- This $740,709 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research at the University of Utah on the role of type 2 innate lymphoid cells (ILC2s) in mediating the development of childhood asthma. The research aims to define how early-life inflammation, particularly viral infections in the first 1-2 years of life, can reprogram hematopoietic progenitor cells to produce hyperactivated, tissue-resident ILC2s that...